Heidelberg Pharma – turning deadly mushroom toxin into cancer medicine

Update: 2024-09-12

Description

It’s time to talk about mushrooms! Or rather the deadly toxin amanitin found in the death cap mushroom, which Heidelberg Pharma is using as a cancer drug with the help of a tumour-targeting antibody, find out more in this episode featuring Heidelberg Pharma's CEO, Andreas Pahl.

Hosted on Acast. See acast.com/privacy for more information.

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

Kling Biotherapeutics: Using B cell tech to discover new targets and antibodies in cancer

2024-11-2109:17

DISCO Pharmaceuticals looks to unlock new drugs with “surfaceome” technology

2024-11-0515:51

SpliceBio: Celebrating progress in ophthalmology research on World Sight Day

2024-10-1011:42

Heidelberg Pharma – turning deadly mushroom toxin into cancer medicine

2024-09-1214:24

Resolution Therapeutics: pioneering macrophage therapies for liver diseases

2024-08-0827:55

Q&A with Dr Ruth McKernan CBE: Neuroscientist, businesswoman and innovation leader

2024-07-2521:42

How AI is revolutionising drug research

2024-05-3023:39

Curve Therapeutics – Addressing challenging drug targets

2024-05-2312:39

Biotech IPOs make a comeback in 2024

2024-05-1620:55

Anglonordic Life Science Conference strikes optimistic note for ‘24

2024-05-0709:12

The challenges of recruitment for clinical trials

2024-04-0424:16

Lytix Biopharma – Innovations in Killing Cancer

2024-03-0717:07

Tackling Rare Diseases in 2024

2024-02-2938:09

International Day of Women & Girls in Science: Breaking barriers and channeling your inner cavewoman

2024-02-0827:40

Optimum's European Life Sciences Investor Survey 2024

2024-01-2317:46

Vicore Pharma: Restoring lung function for IPF patients

2023-12-1211:29

Optimum's Christmas charity special featuring Ariana Smiles

2023-12-0616:28

4SC: Creating a new treatment paradigm for CTCL

2023-11-2117:30

Episode 10: Optimum's 15th Annual Healthcare Investor Conference Special

2023-11-0208:45

Ask Eva: biopharma's market trends in 2023

2023-09-0714:09

00:00

1.0x

Heidelberg Pharma – turning deadly mushroom toxin into cancer medicine

#box-pro-ellipsis-173235420898019{-webkit-line-clamp:2;}Heidelberg Pharma – turning deadly mushroom toxin into cancer medicine

Heidelberg Pharma – turning deadly mushroom toxin into cancer medicine

Heidelberg Pharma – turning deadly mushroom toxin into cancer medicine